Pharma R&D & Clinical Services · Indirect
Monitoring · monthlyProcurement Category Intelligence
Phase I Clinical Trials
Overview
Market size
$8.4B
global, USD
CAGR
7.2%
base to forecast
Buyer power
-2.6
supplier-favoured
Suppliers
6
tracked players
Signals
12
6 high severity
Market outlook
2031$11.9B
What changed
Demand by region
North America demand45%
Asia Pacific demand30%
Europe demand18%
Rest of world demand7%
share of global demandtotal 100%
Cost drivers
Clinical Investigator and Research Labor35%
Clinical Pharmacology Unit (CPU) and Site Operations25%
Clinical Procedures, Labs, and Biomarker Assays15%
Data Management and Biostatistics15%
Regulatory Affairs and Ethics Committee Compliance10%
share of delivered cost (analyst estimate)